Pharma giant Moderna (MRNA) is set to release its Q4 2024 results on February 14. MRNA stock has lost about 64% over the past ...
Cells in the body have to move around in order to do their jobs. During development, for instance, cells are distributed to ...
A bill that would ban the use of mRNA vaccines, including for Covid-19, is on its way to the House floor after passing out of ...
When Xiao Wang applied to faculty jobs, many of the institutions where she interviewed thought her research proposal - to ...
In principle, mRNA vaccines are ideal for health emergencies as they can be quickly mass produced using a template. The problem is that current cell-based template production methods take too long, ...
The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...
A complex molecular machine, the spliceosome, ensures that the genetic information from the genome, after being transcribed ...
POSTECH Professor Won Jong Kim’s Team Develops a Next-Generation mRNA Vaccine Delivery System Using Biodegradable Polymers.
MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback